Aquaculture Vaccines Market

Aquaculture Vaccines Market Size

Estimated to have 7.6% CAGR between 2023 and 2032, aquaculture vaccines market size exceeded USD 214.6 million in 2022. Rising supply, changing consumer tastes and preferences, technical developments, and wage inflation are driving aquatic food consumption higher. Therefore, the growing aquaculture sector is projected to increase the requirement for aquaculture vaccines for increased output, so stimulating the worldwide market demand over the projection period.

To get key market trends

  Download Free Sample

For a number of reasons, the market for aquaculture vaccines is likely to expand. increasingly infections in fishRising demand for vaccinations results from infectious diseases becoming increasingly frequent in fish. Companies are creating fresh, better vaccinations to treat these illnesses. Industry innovationConstant innovation in the aquaculture sector results in the creation of fresh technology and goods like vaccinations. Government rules could, however, impede down the expansion of the aquaculture vaccination business. Governments have tight policies in place to guarantee that fish find vaccines safe and efficient. Approval of a vaccination for use in fish can take a protracted period. Extensive research and development of novel vaccines can be costly, so smaller businesses may find it challenging to enter the market. Notwithstanding these difficulties, the market for aquaculture vaccines is predicted to expand in next years. This is so because vaccinations are a vital weapon for shielding fish from diseases and the demand for fish and seafood is rising.

What are the growth opportunities in this market?

 Download Free Sample

Increasing demand for aquaculture vaccines for higher production to proliferate the market growth

The market expansion is expected to be multiplied by the growing need of aquaculture vaccines for greater food output obtained from animals. Recent years have seen fast expansion in the aquaculture sector. Since it greatly helps to provide premium protein meals for humans, a sustainable aquaculture company is absolutely vital for the global food supply and economy. Plant genetic engineering, which has also been applied to generate vaccines, helps in the production of genetically modified crops with desirable features as well.

Aquaculture Vaccines Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

The aquaculture vaccines market is divided depending on kind of vaccination as Inactivated vaccine, Live vaccination, and others. By 2032, the inactive vaccines category is predicted to be worth over USD 362.1 million. When new mutant strains develop, antibiotics and probiotics seem to be less effective; disease-causing bacteria also acquire resistance to commonly used antibiotics. Consequently, vaccinations generated by lowering molecular techniques can be considered as a successful approach of treating disease-causing in aquatic organisms and help to increase immunity to a given disease or group of infections.

Learn more about the key segments shaping this market

 Download Free Sample

Aquaculture vaccines market is divided depending on Route of Administration as Immersion vaccines, Injection vaccines, Oral vaccines, and others. About USD 139.1 million in 2022 will come from the market on injection vaccinations. Fish can get an antibody response effectively from injection vaccinations. Either intraperitoneal or intramuscular, the injection could be Most immunizations for aquaculture fight bacterial diseases. They can be administered orally or by injection—intraperitoneal or intramuscular.

Application drives the segmentation of the aquaculture vaccines market as Bacterial infection, Viral infection, and others. Estimated to have a profitable CAGR of over 7.5% from 2023 to 2032 is the section on bacterial infections. Germs invading the body grow and cause a reaction that results in a bacterial infection. Using modern, reasonably priced molecular technologies combined with vaccines developed approaches efficiently treats disease-causing bacteria in aquatic life.

Looking for region specific data?

 Download Free Sample

By 2032, Norway aquaculture vaccines market is expected to be valued more than USD 96.16 million. Several reasons contribute to the notable market shareexistence of big market players, growing demand for Aquaculture Vaccines, and better supply chains for the vaccines. Several local market companies are working on new product development and commercialization that supports industrial growth in aquaculture by means of aquaculture vaccination.

By working with fish vaccine specialist Skala Maskon, ScaleAQ hopes to extend its value chain to become a whole supplier and partner to the farming industry in January 2023. This is a strategic and important transaction that combines the supply company of aquaculture with a diversified and strong knowledge environment. It would help the business to be a complete provider of agriculture sector essential infrastructure. Consequently, over the study period, the above mentioned elements are expected to increase the growth of the European Aquaculture Vaccines market.

Aquaculture Vaccines Market Share

Some of the major market players operating in the Aquaculture Vaccines industry are

• Zoetis Inc.
• Merck & Co., Inc
• HIPRA
• Tecnovax
• Virbac
• Veterquimica S.A
• Nisseiken Co. Ltd.
• Phibro Animal Health Corporation
• Vaxxinova International BV
• Kyoto Biken Laboratories, Inc.

These organizations are concentrating their efforts on strategic partnerships, mergers, and acquisitions to maintain their competitive advantage. For instance, In July 2020, Zoetis acquired Benchmark Holdings, Plc Fish Vet Company to expand the company's global presence and analytical skills.

Impact of COVID-19 pandemic

The outbreak of the COVID-19 pandemic in 2020 hindered aquaculture vaccine manufacturing throughout the globe. The overall business performance was affected by a substantial increase in the spread of illness and pandemic-related disease and death, as well as major supply chain disruptions. Owing to lockdown constraints and social distancing conventions, aquaculture vaccine production has been hampered by a labour shortage and an increased focus on making COVID-19 vaccines.

Aquaculture Vaccines market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments

Click here to Buy Section of this Report

By Type of vaccines

• Inactivated vaccines
• Live vaccines
• Others

By Route of Administration

• Immersion vaccines
• Injection vaccines
• Oral vaccines

By Application

• Bacterial infection
• Viral infection
• Others

By Species

• Salmon
• Trout
• Tilapia
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Norway
  • Ireland
  • Turkey
  • Denmark
• Asia Pacific
  • China
  • Indonesia
  • Philippines
  • Thailand
  • Australia
  • New Zealand 
• Latin America
  • Brazil
  • Mexico
  • Chile
• Middle East & Africa
  • Iran
  • Egypt